Skip to main content
. 2020 Aug 18;10:13948. doi: 10.1038/s41598-020-70733-4

Table 1.

Experimental subject description of healthy and ischemic heart disease (diastolic and systolic) of serum samples.

Patient characteristics Disease Healthy p-value
Number of samples 62 55
Gender (male/female) 54/8 44/11
Age male (years; µ ± σ) 58.90 ± 8.34 31.3 ± 6.41 2 × 10–33
Age female (years; µ ± σ) 58.12 ± 9.51 30.18 ± 9.03 3 × 10–5
Height (cm) 163.80 ± 8.91 167.32 ± 7.95 0.0649
Body weight (Kg) 72.41 ± 11.94 65.49 ± 6.99 8 × 10–5
BMI (Kg/m2) 26.66 ± 4.83 23.59 ± 3.64 0.0007
SBP (mm Hg) 129.46 ± 18.60 112.91 ± 10.48 1 × 10–7
DBP (mm Hg) 75.67 ± 9.69 72.27 ± 8.65 0.0394
Medical history Frequency
Diabetes/non-diabetes 37/25 0/55
Hypertension/non-hypertension 41/21 0/55
Chest pain/non-chest pain 48/14 0/55
Current smoker/non-smokers 11/51 0/55
Hypercholesterolemia/non-hypercholesterolemia 6/56 0/55
Echocardiographic parameters
Ejection fraction (< 45%/ > 45%) 12/50
Grades 0–1/1A and 2) 45/4/and 5
E/e′ (< 8/9–15 and > 15) 12/33 and 7
Biochemical parameters
Creatinine (mg/dl) 0.99 ± 0.26
BUN (mg/dl) 17.74 ± 7.85
Random blood glucose (mg/dl) 183.67 ± 64.81
Fasting blood glucose (mg/dl) 164.96 ± 57.98

µ mean, σ standard deviation, BMI body mass index, SBP systolic blood pressure, DBP diastolic blood pressure, BUN blood urea nitrogen.